Host-pathogen interactions are dynamic processes that encompass the techniques employed by pathogens to infect and overcome immune systems, as well as the ...

Argent BioPharma , a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments for central nervous system and immune-related disorders through ...

The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.

Published extended data from the phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting MS in the peer reviewed journal, Neurology® Neuroimmunology & Neuroinflammation, an official ...

Published extended data from the phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting MS in the peer reviewed journal, Neurology® Neuroimmunology & Neuroinflammation, an official ...

Zoonotic diseases, also known as zoonoses, bridge the gap between animal and human health, marking a prominent area of concern for global public health.

This manuscript offers valuable insights by identifying two distinct liver cancer subtypes through multi-omics integration and developing a robust prognostic model, validated across various datasets, ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The study reports on two ...

The “normal and robust” immune response exhibited has become what is considered to be the “gold standard” for developing human antibody therapeutics. Meanwhile, discussing the company’s ...

As a result, he continued, "the most advanced drugs are too costly to help as many people as they could. In emerging fields such as gene and cell therapy, better manufacturing technology is ...